Exelixis (EXEL) News Today $39.60 +0.71 (+1.83%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$39.80 +0.20 (+0.52%) As of 05/2/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period 13D Management LLC Sells 131,965 Shares of Exelixis, Inc. (NASDAQ:EXEL)13D Management LLC lowered its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 36.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 228,610 shares of the biotechnology company's stock after seMay 4 at 7:44 AM | marketbeat.comCaisse DE Depot ET Placement DU Quebec Grows Stake in Exelixis, Inc. (NASDAQ:EXEL)Caisse DE Depot ET Placement DU Quebec grew its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 330.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,484,395 shares of the biotechnology company's stock after buyingMay 4 at 5:46 AM | marketbeat.comExelixis (NASDAQ:EXEL) vs. Allogene Therapeutics (NASDAQ:ALLO) Financial SurveyMay 4 at 1:41 AM | americanbankingnews.comExelixis, Inc. (EXEL): Among the Large-Cap Stocks Insiders and Short Sellers Are Dumping Like CrazyMay 3 at 3:59 PM | insidermonkey.comWhat is William Blair's Forecast for Exelixis Q1 Earnings?Exelixis, Inc. (NASDAQ:EXEL - Free Report) - Investment analysts at William Blair issued their Q1 2026 earnings estimates for shares of Exelixis in a note issued to investors on Monday, April 28th. William Blair analyst A. Hsieh forecasts that the biotechnology company will post earnings per sharMay 3 at 8:36 AM | marketbeat.comEquities Analysts Set Expectations for Exelixis Q1 EarningsMay 3 at 3:29 AM | americanbankingnews.comEquities Analysts Offer Predictions for Exelixis Q1 EarningsExelixis, Inc. (NASDAQ:EXEL - Free Report) - Analysts at Leerink Partnrs boosted their Q1 2025 earnings per share (EPS) estimates for shares of Exelixis in a research note issued to investors on Monday, April 28th. Leerink Partnrs analyst A. Berens now forecasts that the biotechnology company wilMay 2 at 7:49 AM | marketbeat.comAQR Capital Management LLC Has $132.10 Million Position in Exelixis, Inc. (NASDAQ:EXEL)AQR Capital Management LLC lifted its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 25.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,967,005 shares of the biotechnology company's stock after purchaMay 2 at 6:09 AM | marketbeat.comVoya Investment Management LLC Sells 116,111 Shares of Exelixis, Inc. (NASDAQ:EXEL)Voya Investment Management LLC cut its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 30.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 270,588 shares of the biotechnology company's stock after sellinMay 1 at 5:39 AM | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD trimmed its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 6.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,766,841 shares of the biotechnoMay 1 at 5:11 AM | marketbeat.comTower Research Capital LLC TRC Buys 13,111 Shares of Exelixis, Inc. (NASDAQ:EXEL)Tower Research Capital LLC TRC grew its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 172.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,703 shares of the biotechnology company's stock aftApril 30, 2025 | marketbeat.comIs the Market Bullish or Bearish on Exelixis?April 29, 2025 | benzinga.comSusquehanna Fundamental Investments LLC Acquires New Shares in Exelixis, Inc. (NASDAQ:EXEL)Susquehanna Fundamental Investments LLC bought a new position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 361,998 shares of the biotechnology company's stock, valued at approximaApril 29, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Boothbay Fund Management LLCBoothbay Fund Management LLC lessened its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 1.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 804,015 shares of the biotechnology company's stock after selling 10,945 shares during the quartApril 28, 2025 | marketbeat.comSyon Capital LLC Purchases New Position in Exelixis, Inc. (NASDAQ:EXEL)Syon Capital LLC acquired a new position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 9,403 shares of the biotechnology company's stock,April 28, 2025 | marketbeat.comNewEdge Advisors LLC Grows Holdings in Exelixis, Inc. (NASDAQ:EXEL)NewEdge Advisors LLC grew its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 113.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,908 shares of the biotechnology company's stock after purchasing an addApril 28, 2025 | marketbeat.comPinebridge Investments L.P. Reduces Position in Exelixis, Inc. (NASDAQ:EXEL)Pinebridge Investments L.P. decreased its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 21.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 149,367 shares of the biotechnology company's sApril 27, 2025 | marketbeat.comDark Forest Capital Management LP Grows Position in Exelixis, Inc. (NASDAQ:EXEL)Dark Forest Capital Management LP lifted its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 39.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,176 shares of the biotechnology cApril 27, 2025 | marketbeat.comExelixis Reaches Analyst Target PriceApril 26, 2025 | nasdaq.comMercadoLibre, The Amazon Of Latin America, Leads Five Stocks Near Buy PointsApril 26, 2025 | investors.comMetLife Investment Management LLC Purchases 12,894 Shares of Exelixis, Inc. (NASDAQ:EXEL)MetLife Investment Management LLC grew its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 8.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 171,209 shares of the biotechnology company's stock after acquiring an additional 12,894 sharesApril 26, 2025 | marketbeat.comDimensional Fund Advisors LP Decreases Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)Dimensional Fund Advisors LP cut its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 2.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,099,406 shares of the biotechnology company's stockApril 26, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Acquired by Fuller & Thaler Asset Management Inc.Fuller & Thaler Asset Management Inc. boosted its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 10.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,630,940 shares of the biotechnology company's stock after acApril 25, 2025 | marketbeat.comForum Financial Management LP Purchases New Holdings in Exelixis, Inc. (NASDAQ:EXEL)Forum Financial Management LP purchased a new position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 7,244 shares of the biotechnology company's stock, valued at approximately $April 25, 2025 | marketbeat.comCANADA LIFE ASSURANCE Co Has $8 Million Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)CANADA LIFE ASSURANCE Co reduced its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 16.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 240,365 shares of the biotechnology company's stock after selling 46,445 shares during the period. CANADA LIFE ASApril 25, 2025 | marketbeat.comMassar Capital Management LP Acquires Shares of 53,706 Exelixis, Inc. (NASDAQ:EXEL)Massar Capital Management LP bought a new position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 53,706 shares of the biotechnology company's stock, valued at approximApril 24, 2025 | marketbeat.comExelixis (EXEL) to Release Quarterly Earnings on TuesdayExelixis (NASDAQ:EXEL) will be releasing its Q1 2025 earnings before the market opens on Tuesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-4-29-exelixis-inc-stock/)April 24, 2025 | marketbeat.comFirst Trust Advisors LP Sells 328,754 Shares of Exelixis, Inc. (NASDAQ:EXEL)First Trust Advisors LP lessened its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 11.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,539,863 shares of the biotechnology company's stock after selling 328,754April 24, 2025 | marketbeat.comMarshall Wace LLP Sells 36,327 Shares of Exelixis, Inc. (NASDAQ:EXEL)Marshall Wace LLP reduced its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 9.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 338,284 shares of the biotechnology company'April 24, 2025 | marketbeat.comCanada Pension Plan Investment Board Sells 207,000 Shares of Exelixis, Inc. (NASDAQ:EXEL)Canada Pension Plan Investment Board trimmed its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 32.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 433,400 shares of tApril 23, 2025 | marketbeat.comBarclays PLC Increases Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)Barclays PLC grew its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 8.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 348,009 shares of the biotechnology company's stock after buying anApril 23, 2025 | marketbeat.comCommerce Bank Lowers Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)Commerce Bank lessened its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 23.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 144,688 shares of the biotechnology company's stock after selling 43,610 shares during tApril 22, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Guggenheim Capital LLCGuggenheim Capital LLC cut its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 33.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 74,952 shares of the biotechnology company's stock after selling 36April 22, 2025 | marketbeat.com511,879 Shares in Exelixis, Inc. (NASDAQ:EXEL) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. purchased a new stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 511,879 shares of the biotechnology company's stock, valued at approximately $17,046April 22, 2025 | marketbeat.comEnvestnet Asset Management Inc. Has $6.67 Million Stock Position in Exelixis, Inc. (NASDAQ:EXEL)Envestnet Asset Management Inc. boosted its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 17.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 200,228 shares of the biotechnology company's stock afterApril 22, 2025 | marketbeat.comAlpha DNA Investment Management LLC Makes New $479,000 Investment in Exelixis, Inc. (NASDAQ:EXEL)Alpha DNA Investment Management LLC purchased a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 14,397 shares of the biotechnology company's stock, valued at approximately $479,000. OtheApril 21, 2025 | marketbeat.comJMP Securities Reiterates "Market Outperform" Rating for Exelixis (NASDAQ:EXEL)JMP Securities reiterated a "market outperform" rating and set a $41.00 target price on shares of Exelixis in a research report on Thursday.April 19, 2025 | marketbeat.comEAM Global Investors LLC Purchases New Shares in Exelixis, Inc. (NASDAQ:EXEL)EAM Global Investors LLC acquired a new position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 108,564 shares of the biotechnology company's stock, valuedApril 18, 2025 | marketbeat.comEAM Investors LLC Purchases New Position in Exelixis, Inc. (NASDAQ:EXEL)EAM Investors LLC purchased a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 177,786 shares of the biotechnology company's stock, valued at aApril 18, 2025 | marketbeat.comOntario Teachers Pension Plan Board Boosts Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)Ontario Teachers Pension Plan Board grew its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 32.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 47,545 shares of the biotechnology company's stockApril 18, 2025 | marketbeat.com30,949 Shares in Exelixis, Inc. (NASDAQ:EXEL) Acquired by XTX Topco LtdXTX Topco Ltd bought a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 30,949 shares of the biotechnology company's stock, valued at approximately $1,031,000. SeveraApril 18, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Bank of Montreal CanBank of Montreal Can cut its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 10.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 93,921 shares of the biotechnology company's stock after sellApril 18, 2025 | marketbeat.comCerity Partners LLC Buys 45,890 Shares of Exelixis, Inc. (NASDAQ:EXEL)Cerity Partners LLC grew its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 163.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 73,884 shares of the biotechnology company's stock after acquiring an additional 45,890 sharesApril 18, 2025 | marketbeat.comFmr LLC Has $98.16 Million Holdings in Exelixis, Inc. (NASDAQ:EXEL)Fmr LLC lifted its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 19.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,947,599 shares of the biotechnology company's stock after buying an additiApril 18, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Position Boosted by Summit Investment Advisors Inc.Summit Investment Advisors Inc. boosted its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 28.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 75,200 shares of the biotechnology company's stocApril 17, 2025 | marketbeat.comTreasurer of the State of North Carolina Sells 8,450 Shares of Exelixis, Inc. (NASDAQ:EXEL)Treasurer of the State of North Carolina reduced its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 5.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 151,548 shares of the biotechnologApril 17, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Given Average Rating of "Moderate Buy" by BrokeragesShares of Exelixis, Inc. (NASDAQ:EXEL - Get Free Report) have been assigned an average rating of "Moderate Buy" from the twenty ratings firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eight have issuedApril 16, 2025 | marketbeat.comLegal & General Group Plc Decreases Holdings in Exelixis, Inc. (NASDAQ:EXEL)Legal & General Group Plc reduced its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 4.6% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 576,058 shares of the biotechnology company's stock after selling 27,755 shares during the quarter. Legal & GApril 16, 2025 | marketbeat.comInvesco Ltd. Acquires 3,001,204 Shares of Exelixis, Inc. (NASDAQ:EXEL)Invesco Ltd. increased its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 308.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,975,241 shares of the biotechnology company's stock after acquiringApril 15, 2025 | marketbeat.comWells Fargo & Company MN Has $24.85 Million Stake in Exelixis, Inc. (NASDAQ:EXEL)Wells Fargo & Company MN grew its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 1,637.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 746,286 shares of the biotechnology company'April 15, 2025 | marketbeat.com Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address EXEL Media Mentions By Week EXEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXEL News Sentiment▼1.250.73▲Average Medical News Sentiment EXEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXEL Articles This Week▼2313▲EXEL Articles Average Week Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Biogen News United Therapeutics News BioMarin Pharmaceutical News Incyte News Neurocrine Biosciences News Exact Sciences News Repligen News Halozyme Therapeutics News Madrigal Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXEL) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exelixis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EXEL Stock Free EXEL Stock Alerts